Skip to main content

Prophylactic use of timolol maleate to prevent intraocular pressure elevation after Nd-YAG laser posterior capsulotomy

Abstract

Purpose

To evaluate the effective prophylaxis of topical 0.5% timolol maleate for the intraocular pressure rise following Nd-YAG laser posterior capsulotomy.

Methods

A total of 190 eyes of 184 patients who underwent Nd-YAG laser posterior capsulotomy were randomly assigned to pre-treatment with either topical application of 0.5% timolol maleate (treatment group) or nothing (control group).

Results

The mean intraocular pressure (IOP) of the treatment group was 14.8 ± 3.0 mmHg before capsulotomy and 15.7 ± 3.4 mmHg after capsulotomy (> 0.05), whereas IOP was 15.1 ± 3.3 mmHg and 17. 2 ± 4.3 mmHg (< 0.05) for the control group. There was no statistically significant difference between the two groups with regard to mean IOP before capsulotomy (> 0.05), but a statistically significant difference was seen between the two groups after capsulotomy (< 0.05). Six of 91 eyes (6.6%, two with aphakia) in the treatment group had an IOP elevation greater than 6 mmHg compared with 14 of 99 eyes (14.1%, eight with aphakia) in the control group (< 0.01).

Conclusion

Pre-treatment with a topical application of 0.5% timolol maleate is effective in preventing IOP elevation after Nd-YAG laser posterior capsulotomy.

This is a preview of subscription content, access via your institution.

References

  1. Ladas ID, Pavlopoulos GP, Kokolakis SN, et al (1993) Prophylactic use of acetazolamide to prevent intraocular pressure elevation following Nd-YAG laser posterior capsulotomy. Br J Ophthalmol 77:136–138

    PubMed  Article  CAS  Google Scholar 

  2. Arieta C, Amaral M, Matuda E, et al (2002) Dorzolamide × apraclonidine in the prevention of the intraocular pressure spike after Nd:YAG laser posterior capsulotomy. Curr Eye Res 25:237–241

    PubMed  Article  Google Scholar 

  3. Silverstone DE, Brint SF, Olander KW, et al (1992) Prophylactic use of apraclonidine for intraocular pressure increase after Nd:YAG capsulotomies. Am J Ophthalmol 113:401–405

    PubMed  CAS  Google Scholar 

  4. Silverstone DE, Novack GD, Kelley EP, et al (1988) Prophylactic treatment of intraocular pressure elevations after neodymium:YAG laser posterior capsulotomies and extracapsular cataract extractions with levobunolol. Ophthalmology 95:713–718

    PubMed  CAS  Google Scholar 

  5. Richter CU, Arzeno G, Pappas HR, et al (1985) Prevention of intraocular pressure elevation following neodymium-YAG laser posterior capsulotomy. Arch Ophthalmol 103:912–915

    PubMed  CAS  Google Scholar 

  6. Javitt JC, Tielsch JM, Canner JK, et al (1992) National outcomes of cataract extraction. Increased risk of retinal complications associated with Nd:YAG laser capsulotomy. The Cataract Patient Outcomes Research Team. Ophthalmology 99:1487–1497

    PubMed  CAS  Google Scholar 

  7. Cai JP, Zhou H, Wei RL, et al (2002) Nd:YAG laser capsulotomy for the treatment of posterior capsular opacity after cataract surgery. Bull China Second Military Med Univ 23:98–99

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Ji-Ping Cai.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cai, JP., Cheng, JW., Wei, RL. et al. Prophylactic use of timolol maleate to prevent intraocular pressure elevation after Nd-YAG laser posterior capsulotomy. Int Ophthalmol 28, 19–22 (2008). https://doi.org/10.1007/s10792-007-9101-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-007-9101-6

Keywords

  • Nd-YAG laser
  • Posterior capsulotomy
  • Intraocular pressure
  • Timolol maleate